Search - tctmd.com

Displaying 201 - 220 of 264

Sort: Relevancy | Date

News Daily News

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

L.A. McKeown

May 06, 2015

Presentation

Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis

Presenter: Azeem Latib

May 05, 2015

Presentation BRS 2015

Complex Bifurcation Disease Case #1 (Left Main)

Presenter: Azeem Latib

February 10, 2015

Presentation TCT 2014

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Azeem Latib

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Arif Al Nooryani

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Yoshinobu Onuma

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Jens Flensted Lassen

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, John A. Ormiston

September 15, 2014

Presentation TCT 2014

IVUS to Guide Bioresorbable Scaffold Implantation

Presenter: Patrick A. Calvert, Gary S. Mintz, Bernhard Witzenbichler, Azeem Latib

September 15, 2014

Presentation TCT 2014

Understanding Anatomy-Device Interactions of Different Bifurcation Stent Techniques: Insights From the Visible Heart Lab

Presenter: Francesco Burzotta, Paul A. Iaizzo, Ajay J. Kirtane, Azeem Latib

September 15, 2014

Presentation TCT 2014

Valve Thrombus After TAVR: Frequency, Clinical Recognition, and Management

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Anatomical and Procedural Factors Associated with Aortic Root Rupture During TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Marco Barbanti

September 14, 2014

Presentation TCT 2014

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Henrique B. Ribeiro

September 14, 2014

Presentation TCT 2014

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib

September 14, 2014

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

Presentation TCT 2014

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Philippe Généreux

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Presentation TCT 2014

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Stephan Windecker

September 14, 2014

Presentation TCT 2014

Case #8: TAP Application for BRS

Presenter: Evald H. Christiansen, George D. Dangas, Andrejs Erglis, Azeem Latib

September 14, 2014

Presentation TCT 2014

Acute Coronary Syndromes (Including STEMI)

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Bruno Scheller

September 13, 2014

Advertisement

La Trombosis Valvular Post-TAVR podría ser Más Habitual de lo que se Creía

Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis

Complex Bifurcation Disease Case #1 (Left Main)

What Kind of Lesions are BRS Preferred in TODAY? TOMORROW?

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

IVUS to Guide Bioresorbable Scaffold Implantation

Understanding Anatomy-Device Interactions of Different Bifurcation Stent Techniques: Insights From the Visible Heart Lab

Valve Thrombus After TAVR: Frequency, Clinical Recognition, and Management

Anatomical and Procedural Factors Associated with Aortic Root Rupture During TAVR

Risks, Consequences, and Treatment of Coronary Occlusion During TAVR

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Bleeding Events (Early and Late) After TAVR: An Important and Often Misunderstood Complication

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Vascular Complications After TAVR: Changing Frequency, Clinical Impact, and Optimal Management

Case #8: TAP Application for BRS

Acute Coronary Syndromes (Including STEMI)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content